Interleukin-2 inhibitors in autoimmune disease

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.9, Iss.1, 1999-01, pp. : 27-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FLT3 inhibitors for the treatment of autoimmune disease

By Whartenby Katharine A Small Donald Calabresi Peter A

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1685-1692

Informa Healthcare

Access to resources Recommend Favorite

Immunological Mechanisms of Interleukin-2 (IL-2) Treatment in HIV/AIDS Disease

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 40-45

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-2/tumour infiltrating lymphocytes: Ocular and systemic autoimmune disorders: case report

Reactions Weekly, Vol. 1, Iss. 1256, 2009-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite

Apoptosis and Autoimmune Disease

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 4, 2005-08 ,pp. : 429-437

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial Chemokines in Autoimmune Disease

Current Pharmaceutical Design, Vol. 10, Iss. 2, 2004-01 ,pp. : 145-154

Bentham Science Publishers

Access to resources Recommend Favorite